What does high total cholesterol mean?

High total cholesterol (above 200 mg/dL) indicates elevated levels of lipids in your blood, increasing cardiovascular disease risk. It results from genetics, diet, lifestyle factors, or underlying conditions and requires management through lifestyle changes and sometimes medication.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Total Cholesterol and Its Components

Total cholesterol is a measurement that represents the sum of all cholesterol types circulating in your bloodstream. This includes low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and very low-density lipoprotein (VLDL) cholesterol. While cholesterol often gets a bad reputation, your body actually needs this waxy, fat-like substance to build healthy cells, produce hormones, and create vitamin D.

The key lies in maintaining the right balance. Your liver produces about 80% of the cholesterol your body needs, while the remaining 20% comes from dietary sources. When this delicate balance tips toward excess, particularly with too much LDL cholesterol or too little HDL cholesterol, health problems can arise.

Breaking Down the Numbers

According to the National Heart, Lung, and Blood Institute, total cholesterol levels are categorized as follows:

Understanding Cholesterol Components and Target Levels

Cholesterol TypeFunctionOptimal LevelHealth Impact
Total CholesterolTotal CholesterolSum of all cholesterol types<200 mg/dLGeneral cardiovascular risk indicator
LDL CholesterolLDL ('Bad') CholesterolCarries cholesterol to arteries<100 mg/dL (optimal)Primary driver of atherosclerosis
HDL CholesterolHDL ('Good') CholesterolRemoves excess cholesterol>40 mg/dL (men), >50 mg/dL (women)Protective against heart disease
TriglyceridesTriglyceridesStores unused calories<150 mg/dLIncreases with sugar/carb intake
Non-HDL CholesterolNon-HDL CholesterolTotal minus HDL<130 mg/dLBetter risk predictor than LDL alone

Target levels may vary based on individual cardiovascular risk factors and medical history.

  • Desirable: Less than 200 mg/dL
  • Borderline high: 200-239 mg/dL
  • High: 240 mg/dL and above

However, total cholesterol alone doesn't tell the complete story. The ratio of different cholesterol types matters significantly. For instance, you could have a total cholesterol of 220 mg/dL, which seems borderline high, but if most of it consists of protective HDL cholesterol, your cardiovascular risk might actually be lower than someone with a total cholesterol of 190 mg/dL but very low HDL levels.

The Role of Different Cholesterol Types

LDL cholesterol, often called 'bad' cholesterol, carries cholesterol particles throughout your body and can build up in artery walls, making them hard and narrow. HDL cholesterol, the 'good' cholesterol, picks up excess cholesterol and takes it back to your liver for disposal. VLDL cholesterol, produced by your liver, carries triglycerides to tissues and eventually converts to LDL cholesterol.

Understanding these components helps explain why two people with the same total cholesterol might have vastly different cardiovascular risk profiles. This is why comprehensive lipid testing that breaks down these components provides more actionable health insights than total cholesterol alone.

What Causes High Total Cholesterol?

High total cholesterol results from a complex interplay of genetic, dietary, and lifestyle factors. Understanding these causes helps you identify which factors you can control and which might require medical intervention.

Genetic Factors

Familial hypercholesterolemia (FH) is an inherited condition affecting about 1 in 250 people worldwide. Individuals with FH have genetic mutations that impair their body's ability to remove LDL cholesterol from the blood, leading to extremely high cholesterol levels from birth. Even with a healthy lifestyle, people with FH often require medication to manage their cholesterol levels effectively.

Beyond FH, your genetic makeup influences how your body produces and processes cholesterol. Some people naturally produce more cholesterol or clear it from their bloodstream less efficiently, making them more susceptible to high cholesterol despite healthy habits.

Dietary and Lifestyle Contributors

Diet plays a crucial role in cholesterol levels, though perhaps not in the way many people think. While dietary cholesterol has less impact than once believed, certain foods significantly affect your cholesterol profile:

  • Saturated fats (found in red meat, full-fat dairy, and tropical oils) increase LDL cholesterol
  • Trans fats (in processed foods) raise LDL and lower HDL cholesterol
  • Refined carbohydrates and added sugars can lower HDL and raise triglycerides
  • Excess calories leading to weight gain affect overall cholesterol metabolism

Physical inactivity compounds these dietary effects. Regular exercise helps raise HDL cholesterol while lowering LDL cholesterol and triglycerides. Smoking damages blood vessel walls, making it easier for cholesterol to accumulate, while also lowering beneficial HDL cholesterol.

Medical Conditions and Medications

Several health conditions can contribute to high cholesterol levels:

  • Diabetes: High blood sugar damages blood vessel linings and often coincides with lower HDL and higher triglycerides
  • Hypothyroidism: An underactive thyroid slows metabolism, including cholesterol clearance
  • Kidney disease: Impairs the body's ability to regulate lipid levels
  • Liver disease: Affects cholesterol production and processing
  • Polycystic ovary syndrome (PCOS): Often associated with abnormal lipid profiles

Certain medications can also raise cholesterol levels, including some diuretics, beta-blockers, and corticosteroids. If you're taking these medications, regular cholesterol monitoring becomes even more important.

Health Risks of High Total Cholesterol

High total cholesterol doesn't cause symptoms on its own, earning it the nickname 'silent killer.' The real danger lies in its long-term effects on your cardiovascular system and overall health.

Cardiovascular Disease Development

When excess cholesterol circulates in your blood, it can gradually deposit along artery walls, forming plaques through a process called atherosclerosis. These plaques narrow arteries and reduce blood flow to vital organs. More dangerously, plaques can rupture, triggering blood clots that may cause heart attacks or strokes.

Research from the American Heart Association shows that every 40 mg/dL reduction in LDL cholesterol correlates with a 20-25% reduction in cardiovascular events. This demonstrates the profound impact that managing cholesterol levels can have on heart health outcomes.

Beyond Heart Disease

While cardiovascular disease remains the primary concern, high cholesterol affects other body systems:

  • Peripheral artery disease: Reduced blood flow to limbs causing pain and mobility issues
  • Cognitive decline: Some studies link high cholesterol to increased dementia risk
  • Gallstones: Excess cholesterol can crystallize in the gallbladder
  • Xanthomas: Cholesterol deposits under the skin, indicating extremely high levels
  • Erectile dysfunction: Reduced blood flow from narrowed arteries

The cumulative effect of high cholesterol over decades makes early detection and management crucial. Regular monitoring through comprehensive lipid panels helps identify problems before irreversible damage occurs.

Advanced Testing Beyond Total Cholesterol

While total cholesterol provides a starting point, advanced lipid testing offers deeper insights into your cardiovascular risk. These tests go beyond the basic lipid panel to measure particle sizes, counts, and additional biomarkers that better predict heart disease risk.

Apolipoprotein B (ApoB) Testing

ApoB represents the total number of atherogenic particles in your blood, as each LDL, VLDL, and intermediate-density lipoprotein particle contains exactly one ApoB protein. Research suggests ApoB may be a better predictor of cardiovascular risk than LDL cholesterol alone, especially in people with diabetes or metabolic syndrome.

The optimal ApoB level is below 90 mg/dL, with levels above 130 mg/dL indicating high risk. This measurement becomes particularly valuable when LDL cholesterol appears normal but cardiovascular risk remains elevated due to a high number of small, dense LDL particles.

Additional Important Markers

Other advanced markers provide a more complete cardiovascular risk assessment:

  • Lipoprotein(a) or Lp(a): A genetic risk factor independent of other cholesterol levels
  • High-sensitivity C-reactive protein (hs-CRP): Measures inflammation that accelerates atherosclerosis
  • Homocysteine: Elevated levels damage artery walls and increase clot risk
  • Particle size analysis: Small, dense LDL particles are more atherogenic than large, fluffy ones

These comprehensive assessments help personalize treatment strategies and identify individuals who might benefit from more aggressive interventions despite seemingly normal total cholesterol levels.

Natural Ways to Lower High Cholesterol

Lifestyle modifications remain the first-line approach for managing high cholesterol, often producing significant improvements without medication. These changes benefit overall health beyond just cholesterol levels.

Dietary Strategies That Work

The most effective dietary approach focuses on food quality rather than strict restriction. The Mediterranean diet pattern, rich in olive oil, nuts, fish, and vegetables, has shown consistent benefits for cholesterol management. Key dietary changes include:

  • Increase soluble fiber intake (oats, beans, apples) to bind cholesterol in the digestive system
  • Add plant sterols and stanols from fortified foods or supplements
  • Choose fatty fish twice weekly for omega-3 fatty acids
  • Replace saturated fats with unsaturated fats from nuts, seeds, and avocados
  • Limit added sugars and refined carbohydrates that worsen triglycerides

Studies show that combining these dietary strategies can lower LDL cholesterol by 20-30%, rivaling the effects of some medications.

Exercise and Lifestyle Modifications

Regular physical activity improves cholesterol profiles through multiple mechanisms. Aerobic exercise raises HDL cholesterol while lowering triglycerides, with benefits appearing after just 8-12 weeks of consistent activity. Aim for at least 150 minutes of moderate-intensity exercise weekly, though more intensive exercise provides greater benefits.

Other crucial lifestyle factors include:

  • Weight loss: Even 5-10% reduction significantly improves cholesterol levels
  • Smoking cessation: HDL levels can increase by 15-20% after quitting
  • Stress management: Chronic stress affects cholesterol metabolism
  • Adequate sleep: Poor sleep quality disrupts lipid metabolism
  • Moderate alcohol consumption: If you drink, limit to one drink daily for women, two for men

When Medication Becomes Necessary

Despite best lifestyle efforts, some individuals require medication to achieve healthy cholesterol levels. This decision depends on overall cardiovascular risk, not just cholesterol numbers alone.

Understanding Statin Therapy

Statins remain the gold standard for cholesterol-lowering medication, reducing LDL cholesterol by 30-50% depending on the dose and specific medication. They work by blocking an enzyme your liver needs to produce cholesterol, forcing your body to remove more LDL from the bloodstream.

Modern guidelines recommend statins based on overall cardiovascular risk rather than cholesterol levels alone. Factors including age, blood pressure, smoking status, and diabetes influence this calculation. Most people tolerate statins well, though some experience muscle aches or other side effects that may require dose adjustment or medication changes.

Alternative and Combination Therapies

For those who cannot tolerate statins or need additional cholesterol reduction, several alternatives exist:

  • Ezetimibe: Blocks cholesterol absorption in the intestines
  • PCSK9 inhibitors: Injectable medications that dramatically lower LDL
  • Bile acid sequestrants: Bind cholesterol in the digestive system
  • Fibrates: Primarily lower triglycerides while modestly raising HDL
  • Niacin: Raises HDL and lowers triglycerides, though less commonly used now

Combination therapy often achieves better results than maximizing a single medication. Regular monitoring ensures medications work effectively while watching for potential side effects.

Taking Control of Your Cholesterol Health

Managing high total cholesterol requires a comprehensive approach combining regular monitoring, lifestyle modifications, and sometimes medication. The key lies in understanding that cholesterol management is a marathon, not a sprint, requiring consistent effort and periodic reassessment.

Start by getting a complete lipid profile that goes beyond total cholesterol to include LDL, HDL, triglycerides, and ideally advanced markers like ApoB. This baseline helps you and your healthcare provider develop a personalized management plan based on your overall cardiovascular risk profile.

Remember that high cholesterol rarely exists in isolation. It often accompanies other metabolic issues like insulin resistance, inflammation, or hormonal imbalances. Addressing these interconnected factors through comprehensive testing and targeted interventions provides the best outcomes for long-term health.

Whether through dietary changes, increased physical activity, stress management, or medication when necessary, taking action to manage high cholesterol today protects your cardiovascular health for decades to come. Regular monitoring helps track progress and adjust strategies as needed, empowering you to take control of this critical aspect of your health.

References

  1. Grundy, S. M., et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology, 73(24), e285-e350.[PubMed][DOI]
  2. Ference, B. A., et al. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal, 38(32), 2459-2472.[PubMed][DOI]
  3. Sniderman, A. D., et al. (2019). Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology, 4(12), 1287-1295.[PubMed][DOI]
  4. Arnett, D. K., et al. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation, 140(11), e596-e646.[PubMed][DOI]
  5. Estruch, R., et al. (2018). Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. New England Journal of Medicine, 378(25), e34.[PubMed][DOI]
  6. Mach, F., et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1), 111-188.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my total cholesterol at home?

You can test your total cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes comprehensive cholesterol testing (total cholesterol, LDL, HDL, triglycerides) plus advanced markers like ApoB and ApoA1, providing lab-quality results from the comfort of your home.

What is the difference between total cholesterol and LDL cholesterol?

Total cholesterol is the sum of all cholesterol types in your blood (LDL + HDL + VLDL), while LDL cholesterol specifically measures the 'bad' cholesterol that can build up in arteries. Total cholesterol gives an overview, but the breakdown of different cholesterol types provides more meaningful health insights.

Can high cholesterol be reversed without medication?

Yes, many people can significantly lower their cholesterol through lifestyle changes alone. Diet modifications, regular exercise, weight loss, and smoking cessation can reduce LDL cholesterol by 20-30%. However, those with genetic conditions or very high levels may still need medication despite lifestyle changes.

How often should I check my cholesterol levels?

If you have high cholesterol or are making lifestyle changes, testing every 3-6 months helps track progress. Once levels stabilize, annual testing may suffice. Those on cholesterol medications typically need testing every 3-4 months initially, then every 6-12 months once stable.

What foods raise cholesterol the most?

Saturated fats (found in red meat, full-fat dairy, and coconut oil) and trans fats (in processed foods) have the strongest cholesterol-raising effects. Refined carbohydrates and added sugars also negatively impact cholesterol by lowering HDL and raising triglycerides.

Is high cholesterol genetic?

Genetics play a significant role in cholesterol levels. Familial hypercholesterolemia affects 1 in 250 people, causing very high cholesterol from birth. Even without this condition, genetic factors influence how your body produces and clears cholesterol, though lifestyle still significantly impacts levels.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details